Your session is about to expire
← Back to Search
Behavioural Intervention
Arm A (MedSupport) for Acute Lymphoblastic Leukemia
N/A
Waitlist Available
Led By Kara M Kelly
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
Study Summary
This trial aims to help families of children with acute lymphoblastic leukemia improve their adherence to medication. Nonadherence to medication is a big problem and can lead to more hospital visits, higher healthcare costs
Who is the study for?
This trial is for families of children with acute lymphoblastic leukemia. It aims to help those struggling with giving their child oral chemotherapy at home. Participants should be willing to undergo surveys, interviews, and use medical devices as part of the study.Check my eligibility
What is being tested?
The MedSupport intervention is being tested to see if it can identify and tackle the reasons why some kids don't take their medication properly. The study includes using electronic health records, collecting biospecimens, and evaluating how well a medical device works.See study design
What are the potential side effects?
Since this trial focuses on adherence rather than a new drug or treatment method, side effects are not typical in the traditional sense but may include discomfort from interviews or issues related to data privacy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Medication adherence
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm A (MedSupport)Experimental Treatment5 Interventions
Participants receive the MedSupport intervention consisting of three components: universal screening for adherence barriers, tailored virtual education enhancement, and communication of barriers to activate multidisciplinary healthcare teams for 12 months. Participants also use the MEMS device to track oral chemotherapy adherence at baseline and follow-up. Patients also undergo blood sample collection throughout the study.
Group II: Arm B (usual care)Active Control6 Interventions
Participants receive usual care consisting of medical consultations and supportive care for 12 months. Participants also use the MEMS device to track oral chemotherapy adherence at baseline and follow-up. Patients also undergo blood sample collection throughout the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 2
~1730
Find a Location
Who is running the clinical trial?
Roswell Park Cancer InstituteLead Sponsor
402 Previous Clinical Trials
30,708 Total Patients Enrolled
Kara M KellyPrincipal InvestigatorRoswell Park Cancer Institute
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are patients currently eligible to participate in this ongoing medical study?
"According to clinicaltrials.gov, the specified trial is presently not open for participant recruitment. Although it was first listed on March 15, 2024 and last revised on March 14, 2024. Despite this trial being closed for enrollment, there are a total of 505 other trials actively seeking participants at this time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger